W1 (Pyridostigmine Bromide Extended-Release 180 mg)
Pill with imprint W1 is Yellow, Capsule-shape and has been identified as Pyridostigmine bromide extended-release 180 mg. It is supplied by Global Pharmaceuticals, Division of Impax Laboratories Inc..
Pyridostigmine is used in the treatment of myasthenia gravis; dysautonomia; reversal of nondepolarizing muscle relaxants; nerve agent pretreatment and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for W1
Pyridostigmine bromide extended-release
- Imprint:
- W1
- Strength:
- 180 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinergic muscle stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Global Pharmaceuticals, Division of Impax Laboratories Inc.
- National Drug Code (NDC):
- 00115-1404
More about pyridostigmine
- Pyridostigmine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 28 Reviews
- Drug class: cholinergic muscle stimulants
Consumer resources
- Pyridostigmine
- Pyridostigmine Extended-Release Tablets
- Pyridostigmine Tablets
- Pyridostigmine Injection
- Pyridostigmine Syrup
Other brands: Mestinon, Regonol, Mestinon Timespan
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
